Nuvectis Pharma, Inc.NVCT

時価総額
$1.1億
PER
2022年
12月31日
2023年
12月31日
Cash and cash equivalents2019
Other current assets00
TOTAL CURRENT ASSETS2019
TOTAL ASSETS2019
TOTAL ASSETS2019
Accounts payables33
Accounts payables33
Payable offering costs0-
Accrued liabilities00
Employee compensation and benefits24
TOTAL CURRENT LIABILITIES67
Payable offering costs0-
TOTAL LIABILITIES67
Accrued liabilities00
Employee compensation and benefits24
Additional paid in capital4666
Accumulated deficit-32-54
Additional paid in capital4666
TOTAL SHAREHOLDERS' EQUITY1412
Accumulated deficit-32-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY2019
TOTAL SHAREHOLDERS' EQUITY1412
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY2019
TOTAL CURRENT LIABILITIES67
TOTAL LIABILITIES67
Additional paid in capital4666
Accumulated deficit-32-54
Additional paid in capital4666
TOTAL SHAREHOLDERS' EQUITY1412
Accumulated deficit-32-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY2019
TOTAL SHAREHOLDERS' EQUITY1412
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY2019
Cash and cash equivalents2019
Other current assets00
TOTAL CURRENT ASSETS2019
TOTAL ASSETS2019
TOTAL ASSETS2019
Accounts payables33
Accounts payables33
Payable offering costs0-
Accrued liabilities00
Employee compensation and benefits24
TOTAL CURRENT LIABILITIES67
Payable offering costs0-
TOTAL LIABILITIES67
Accrued liabilities00
Employee compensation and benefits24
Additional paid in capital4666
Accumulated deficit-32-54
Additional paid in capital4666
TOTAL SHAREHOLDERS' EQUITY1412
Accumulated deficit-32-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY2019
TOTAL SHAREHOLDERS' EQUITY1412
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY2019
TOTAL CURRENT LIABILITIES67
TOTAL LIABILITIES67
Additional paid in capital4666
Accumulated deficit-32-54
Additional paid in capital4666
TOTAL SHAREHOLDERS' EQUITY1412
Accumulated deficit-32-54
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY2019
TOTAL SHAREHOLDERS' EQUITY1412
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY2019